BRO
$67.05+0.49 (+0.74%)
Brown & Brown, Inc.
Recent News
1 Profitable Stock to Own for Decades and 2 Facing Headwinds
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Is Brown & Brown (BRO) Quietly Redefining Its Moat Amid AI Scrutiny and Dealership Expansion?
In recent days, Brown & Brown, Inc. has faced cautious analyst commentary about how artificial intelligence could affect insurance brokerages, while also expanding its dealership-focused capabilities through Brown & Brown Dealer Services’ acquisition of The Protectorate Group Insurance Agency’s assets across the United States. This combination of technology-related scrutiny and continued acquisition-driven expansion highlights how Brown & Brown is balancing potential industry disruption with...
Is Brown & Brown (BRO) Now At An Attractive Price After Its 42% One-Year Decline
If you are wondering whether Brown & Brown's current share price offers value or not, it helps to first frame what recent returns and fundamentals are actually telling you. The stock recently closed at US$69.19, with a 1.1% gain over 30 days but a 42.0% decline over 1 year and a 10.9% decline year to date, which may catch the eye of investors reassessing the risk and reward trade off. Over a longer horizon, Brown & Brown has posted returns of 29.9% over 3 years and 57.9% over 5 years, which...
Brown & Brown, Inc. (BRO) PT Lowered From $82 to $80 at Barclays Amid AI Industry Concerns
We recently compiled a list of the 10 Oversold Insurance Stocks to Buy According to Analysts. Brown & Brown, Inc. (NYSE:BRO) is among the most oversold stocks. TheFly reported on March 11 that Barclays lowered BRO’s price target to $80 from $82, while maintaining an Equal Weight rating on the stock. Barclays acknowledged that worries […]
Is Brown & Brown Stock Underperforming the Nasdaq?
Brown & Brown has considerably underperformed the Nasdaq Composite over the past year, leading analysts to adopt a cautious view of the stock’s future prospects.